ARTICLE | Distillery Therapeutics
Ophthalmic disease
October 10, 2017 8:50 PM UTC
Mouse studies suggest OPN4 gene therapy could help treat end-stage retinal degeneration. In a mouse model of end-stage retinal degeneration, subretinal delivery of an adeno-associated viral serotype 2...
BCIQ Company Profiles